|
Written by Administrator
|
AcureOmics qualifies for SME statusAcureOmics AB has been assigned SME (micro, small and medium-sized enterprizes) status by EMEA (European Medicines Agency). AcureOmics is thus eligible to benefit from the provisions for administrative and financial assistance laid down in Regulation (EC) No 2049/2005. – This is an important first step towards establishing collaborations and gaining access to research networks in the European community, says Jon Gabrielsson, CEO AcureOmics AB. For further information from the SME Office click here Download press release 
|
Pressmeddelande 
